News Releases

Have a media enquiry? Get in touch with our media relations team: info.canada@ipsen.com
16 / 10 / 2018 - Canada
Health Canada approves XERMELO™ (telotristat ethyl) for the treatment of adult patients suffering from refractory carcinoid syndrome diarrhea
XERMELO NOC Press Release English FINAL FOR WEBSITE ( pdf - 161 kB)
11 / 10 / 2018 - MISSISSAUGA, ON (Canada)
Ipsen Canada Appoints Ed Dybka as General Manager
Ipsen Canada Ed Dybka General Manager - FINAL ( pdf - 114 kB)
18 / 09 / 2018 - MISSISSAUGA, ON (Canada)
Health Canada Approves Ipsen’s CABOMETYX™ (cabozantinib) Giving Physicians and Patients a Novel Second-Line Option in the Fight Against Advanced Renal Cell Carcinoma
Cabozantinib NOC Press Release English ( pdf - 250 kB)
15 / 03 / 2018 - MISSISSAUGA, ON (Canada)
Ipsen Announces Health Canada Approval of DYSPORT THERAPEUTIC™ (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Canada_Dysport-Therapeutic-ALL-Press-Release_EN_March-14-2018_FINAL ( pdf - 66 kB)
13 / 02 / 2018 - MISSISSAUGA, ON (Canada)
Health Canada approves Ipsen’s Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)
Somatuline-NOC-News-Release-English ( pdf - 65 kB)
09 / 01 / 2018 - MISSISSAUGA, ON (Canada)
Ipsen Biopharmaceuticals Canada Inc. Announces Health Canada Approval of DYSPORT THERAPEUTIC™ (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Children Aged Two and Older
Canada_Press-Release_Dysport-Therapeutic_PLL ( pdf - 158 kB)
05 / 09 / 2017 - MISSISSAUGA, ON (Canada)
Ipsen Biopharmaceuticals Canada Names Paul Reider Country Manager and Joins Innovative Medicines Canada to Drive Development and Delivery of Key Therapies
Canada-IMC-Membership-and-Country-Manager-Announcement1 ( pdf - 58 kB)
22 / 12 / 2016 - MISSISSAUGA, ON (Canada)
Ipsen Amends Licensing Agreement With Exelixis To Commercialize And Develop Cabozantinib In Canada
Ipsen-Cabozantinib-Press-Release_ENGLISH-FINAL-DEC-221 ( pdf - 52 kB)
23 / 05 / 2016 - MISSISSAUGA, ON (Canada)
Ipsen pledges $10,000 to Red Cross wild fire relief in Alberta
Ipsen-Red-Cross-Donation_FINAL_May-2016_ENG ( pdf - 65 kB)
14 / 10 / 2015 - MISSISSAUGA, ON (Canada)
Ipsen Grand Opening
Grand-Opening-News-Release-English-October-14_FINAL ( pdf - 67 kB)
06 / 10 / 2015 - MISSISSAUGA, ON (Canada)
Health Canada Approves Somatuline Autogel for the treatment of enteropancreatic neuroendocrine tumours (NETs)
CAN_PR_SOMA-Approval-07-08-15_EN ( pdf - 63 kB)
15 / 04 / 2015 - MISSISSAUGA, ON (Canada)
Ipsen Biopharmaceuticals expands to Canada
Ipsen-Canada-Press-Release-FINAL-ENGLISH ( pdf - 99 kB)
Last update 27/08/2018